Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6871079rdf:typepubmed:Citationlld:pubmed
pubmed-article:6871079lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:6871079lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6871079lifeskim:mentionsumls-concept:C0003962lld:lifeskim
pubmed-article:6871079lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:6871079lifeskim:mentionsumls-concept:C0001771lld:lifeskim
pubmed-article:6871079pubmed:issue1lld:pubmed
pubmed-article:6871079pubmed:dateCreated1983-9-9lld:pubmed
pubmed-article:6871079pubmed:abstractTextReplacement of enriched CMRL 1066 medium by cell-free ascites from tumour patients in the human tumour clonogenic assay described by Hamburger and Salmon (1977) increased plating efficiency for ovarian cancer cells by a median of 8-fold (range 0.4-1012 fold). In 40 experiments, two cases had a lower plating efficiency when cultured in cell-free ascites, 10 grew neither in standard medium nor in cell-free ascites and in two cases, growth was only observed in cell-free ascites. With standard medium, we observed 53% growth (greater than 5 colonies/dish) and 41% evaluable for chemosensitivity testing (greater than 30 colonies/dish). With cell-free ascites as culture medium, these figures were 71% and 63%, respectively. While under standard conditions the highest plating efficiency obtained was 0.25%, in 21% of the experiments done with cell-free ascites a plating efficiency higher than 1% was reached. We conclude that cell-free ascites is able to stimulate proliferation of ovarian cancer cells in agar and that the use of it extends the applicability of the clonogenic assay.lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:languageenglld:pubmed
pubmed-article:6871079pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:citationSubsetIMlld:pubmed
pubmed-article:6871079pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6871079pubmed:statusMEDLINElld:pubmed
pubmed-article:6871079pubmed:monthJullld:pubmed
pubmed-article:6871079pubmed:issn0007-0920lld:pubmed
pubmed-article:6871079pubmed:authorpubmed-author:UitendaalM...lld:pubmed
pubmed-article:6871079pubmed:authorpubmed-author:PinedoH MHMlld:pubmed
pubmed-article:6871079pubmed:authorpubmed-author:McVieJ GJGlld:pubmed
pubmed-article:6871079pubmed:authorpubmed-author:HubertH BHBlld:pubmed
pubmed-article:6871079pubmed:issnTypePrintlld:pubmed
pubmed-article:6871079pubmed:volume48lld:pubmed
pubmed-article:6871079pubmed:ownerNLMlld:pubmed
pubmed-article:6871079pubmed:authorsCompleteYlld:pubmed
pubmed-article:6871079pubmed:pagination55-9lld:pubmed
pubmed-article:6871079pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:meshHeadingpubmed-meshheading:6871079-...lld:pubmed
pubmed-article:6871079pubmed:year1983lld:pubmed
pubmed-article:6871079pubmed:articleTitleHuman tumour clonogenicity in agar is improved by cell-free ascites.lld:pubmed
pubmed-article:6871079pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6871079pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6871079lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6871079lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6871079lld:pubmed